FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Nantahala Capital Management, LLC

2. Date of Event Requiring Statement (MM/DD/YYYY)
4/25/2019 

3. Issuer Name and Ticker or Trading Symbol

VIVEVE MEDICAL, INC. [VIVE]

(Last)        (First)        (Middle)

19 OLD KINGS HIGHWAY S, SUITE 200

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

DARIEN, CT 06820       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

5/3/2019 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   6581465   I   Please see footnotes below.   (1) (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Nantahala Capital Management, LLC ("NCM") may be deemed a beneficial owner of securities held for certain private funds and managed accounts for which NCM serves as investment adviser.
(2)  Mr. Wilmot B Harkey and Mr. Daniel Mack may be deemed to be beneficial owners of the securities beneficially owned by NCM, but each of NCM and Wilmot Harkey and Daniel Mack disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein.

Remarks:
The original Form 3 filed by NCM on May 3, 2019 is amended to include Daniel Mack and Wilmot Harkey as reporting persons.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nantahala Capital Management, LLC
19 OLD KINGS HIGHWAY S
SUITE 200
DARIEN, CT 06820

X

Harkey Wilmot B.
C/O NANTAHALA CAPITAL MANAGEMENT, LLC
19 OLD KINGS HIGHWAY S, SUITE 200
DARIEN, CT 06820

X

Mack Daniel
C/O NANTAHALA CAPITAL MANAGEMENT, LLC
19 OLD KINGS HIGHWAY S, SUITE 200
DARIEN, CT 06820

X


Signatures
/s/ Paul E. Rehm 5/7/2019
** Signature of Reporting Person Date

/s/ Wilmot B. Harkey 5/7/2019
** Signature of Reporting Person Date

/s/ Daniel Mack 5/7/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Viveve Medical Charts.
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Viveve Medical Charts.